Neglected tropical diseases (NTDs) remain major public health problems in developing
countries. Reducing the burden of NTDs requires sustained collaborative drug discovery …

Neglected tropical disease (NTD) is a set of 20 deadliest endemic diseases which shows its
presence in most of the developing countries worldwide. Nearly 1 billion of the population …

The study of neglected diseases has not received much attention, especially from public and
private institutions over the last years, in terms of strong support for developing treatment for …

Neglected tropical diseases (NTDs) afflict more than one billion peoples in the world's
poorest countries. The World Health Organization (WHO) has recorded seventeen NTDs in …

Nanomedicine enables unique diagnostic and therapeutic capabilities to tackle problems in
clinical medicine. As multifunctional agents with programmable properties, nanomedicines …

Nanomedicine is an emerging and rapidly evolving field and includes the use of
nanoparticles for diagnosis and therapy of a variety of diseases, as well as in regenerative …

The emergence of co-infections and the evolution of drug-resistant pathogens limit the utility
of current therapies against infections, and developing countries in particular are facing a …

Leishmaniasis and trypanosomiasis (Chagas disease and African sleeping sickness) are
potentially lethal, tropical neglected diseases. These vector-borne protozoal diseases …

Neglected diseases are prevalent in less developed countries and are associated with high
levels of mortality and/or morbidity. The drugs used in clinical practice are toxic, reducing …

Nanotechnology is a growing science that has applications in various areas of medicine.
The composition of nanocarriers for drug delivery is critical to guarantee high therapeutic …